1208008-34-7 Usage
Uses
Used in Organic Synthesis:
(3S)-3-((tert-butyldiphenylsilyloxy)methyl)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane is used as a building block for the synthesis of more complex organic molecules, taking advantage of its unique bicyclic ring structure and functional groups.
Used in Chemical Research and Development:
(3S)-3-((tert-butyldiphenylsilyloxy)methyl)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane is used as a subject of study in chemical research and development, where its properties, reactivity, and potential applications can be further explored and evaluated.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (3S)-3-((tert-butyldiphenylsilyloxy)methyl)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane may be utilized as a starting material or intermediate for the development of new drugs, given its structural complexity and the presence of various functional groups that can be further modified or reacted.
Used in Material Science:
(3S)-3-((tert-butyldiphenylsilyloxy)methyl)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane may also find applications in material science, where its unique structure could be exploited to create novel materials with specific properties, such as improved stability or reactivity under certain conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1208008-34-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,8,0,0 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1208008-34:
(9*1)+(8*2)+(7*0)+(6*8)+(5*0)+(4*0)+(3*8)+(2*3)+(1*4)=107
107 % 10 = 7
So 1208008-34-7 is a valid CAS Registry Number.
1208008-34-7Relevant academic research and scientific papers
BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
-
, (2014/09/16)
Provided herein is a compound of formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof, which can also be used for treating HCV infection or a HCV disorder.
HEPATITIS C VIRUS INHIBITORS
-
, (2011/06/16)
The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection.
HEPATITIS C VIRUS INHIBITORS
-
, (2010/11/03)
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
BI-1H-BENZIMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 70, (2010/04/03)
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
